Literature DB >> 1634896

Delayed wallerian degeneration in the central nervous system of Ola mice: an ultrastructural study.

S K Ludwin1, M A Bisby.   

Abstract

The ultrastructural features of wallerian degeneration in the optic nerves of the mutant mouse, C57BL/Ola, was compared with that occurring in age matched control mice, to determine whether the previously described defect in the peripheral nervous system was present in the central nervous system as well. On ultrastructural examination, marked delay in the rate of degeneration was seen in the Ola mice nerves seen most clearly at all stages up to 4 weeks post-enucleation, following which differences progressively became undetectable. Once degeneration began, however, the pattern and mechanisms were similar to those seen in control animals, with macrophages, oligodendrocytes, and astrocytes apparently behaving similarly. In both the experimental animals and the controls, the rate of degeneration was slower than that seen in the peripheral nervous system. This study confirms a previous electrophysiological study that the defect in this mutant affects axons in both the peripheral and the central nervous systems.

Entities:  

Mesh:

Year:  1992        PMID: 1634896     DOI: 10.1016/0022-510x(92)90160-m

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  19 in total

1.  Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin.

Authors:  Richard Milner; Iain L Campbell
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

Review 2.  Axonal signals and oligodendrocyte differentiation.

Authors:  Maura Bozzali; Lawrence Wrabetz
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 3.  SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.

Authors:  Vamshi K C Nimmagadda; Tapas K Makar; Krish Chandrasekaran; Avinash Rao Sagi; Jayanta Ray; James W Russell; Christopher T Bever
Journal:  J Neuroimmunol       Date:  2016-07-17       Impact factor: 3.478

4.  CNS inflammation and neurodegeneration.

Authors:  Tanuja Chitnis; Howard L Weiner
Journal:  J Clin Invest       Date:  2017-09-05       Impact factor: 14.808

5.  Axonal degeneration as a self-destructive defense mechanism against neurotropic virus infection.

Authors:  Ikuo Tsunoda
Journal:  Future Virol       Date:  2008       Impact factor: 1.831

6.  Acrylamide-induced peripheral neuropathy in normal and neurofilament-deficient Japanese quails.

Authors:  A Takahashi; M Mizutani; C Itakura
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 7.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration.

Authors:  Robert K Koenekoop; Hui Wang; Jacek Majewski; Xia Wang; Irma Lopez; Huanan Ren; Yiyun Chen; Yumei Li; Gerald A Fishman; Mohammed Genead; Jeremy Schwartzentruber; Naimesh Solanki; Elias I Traboulsi; Jingliang Cheng; Clare V Logan; Martin McKibbin; Bruce E Hayward; David A Parry; Colin A Johnson; Mohammed Nageeb; James A Poulter; Moin D Mohamed; Hussain Jafri; Yasmin Rashid; Graham R Taylor; Vafa Keser; Graeme Mardon; Huidan Xu; Chris F Inglehearn; Qing Fu; Carmel Toomes; Rui Chen
Journal:  Nat Genet       Date:  2012-07-29       Impact factor: 38.330

Review 9.  Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme.

Authors:  Rong Grace Zhai; Menico Rizzi; Silvia Garavaglia
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

10.  Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.

Authors:  Catherine Kielar; Thomas M Wishart; Alice Palmer; Sybille Dihanich; Andrew M Wong; Shannon L Macauley; Chun-Hung Chan; Mark S Sands; David A Pearce; Jonathan D Cooper; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2009-07-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.